Limitations in predicting PAM50 intrinsic subtype and risk of relapse score
with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Fernández, Pascual et al Oncotarget, Aceptado
<2 cm
Ki 67 IHC
ROR
0-10%
11-20%
21-30%
>30%
ROR-Low
102 (57.3%)
28 (28.9%)
12 (15.2%)
3 (6.5%)
ROR-Med
52 (29.2%)
44 (45.4%)
25 (31.6%)
8 (17.4%)
ROR High
24 (13.5%)
25 (28.5%)
42 (53.2%)
35 (76.1%)
Total
178
97
79
46
